Order Article Reprints

Ogura W, Ohtsuka K, Matsuura S, Okuyama T, Matsushima S, Yamasaki S, Miyagi H, Sekiguchi K, Ohnishi H, Watanabe T. Can Individuals with Suboptimal Antibody Responses to Conventional Antiviral Vaccines Acquire Adequate Antibodies from SARS-CoV-2 mRNA Vaccination? Viruses. 2022; 14(5):956. https://doi.org/10.3390/v14050956

Ogura, Wataru, Kouki Ohtsuka, Sachiko Matsuura, Takahiro Okuyama, Satsuki Matsushima, Satoko Yamasaki, Hiroyuki Miyagi, Kumiko Sekiguchi, Hiroaki Ohnishi, and Takashi Watanabe. 2022. "Can Individuals with Suboptimal Antibody Responses to Conventional Antiviral Vaccines Acquire Adequate Antibodies from SARS-CoV-2 mRNA Vaccination?" Viruses 14, no. 5: 956. https://doi.org/10.3390/v14050956

Ogura, W., Ohtsuka, K., Matsuura, S., Okuyama, T., Matsushima, S., Yamasaki, S., Miyagi, H., Sekiguchi, K., Ohnishi, H., & Watanabe, T. (2022). Can Individuals with Suboptimal Antibody Responses to Conventional Antiviral Vaccines Acquire Adequate Antibodies from SARS-CoV-2 mRNA Vaccination? Viruses, 14(5), 956. https://doi.org/10.3390/v14050956